Udaya Valluri

Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

Jonathan Barratt, Branislav Andrić, Avtandil Tataradze et al. · Nephrology Dialysis Transplantation · 2021 · 143 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)

Evgeny Shutov, Władysław Sułowicz, Ciro Esposito et al. · Nephrology Dialysis Transplantation · 2021 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause

Genevieve Neal-Perry, Antonio Cano, Samuel Lederman et al. · Obstetrics and Gynecology · 2023 · 110 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)

Botond Csiky, Michael Schömig, Ciro Esposito et al. · Advances in Therapy · 2021 · 106 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate‐to‐severe plaque psoriasis

Mysore S. Anil Kumar, Kim Papp, Ryo Tainaka et al. · Biopharmaceutics & Drug Disposition · 2018 · 31 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11